Lifecore Biomedical Inc (LFCR)
5.20
-0.07
(-1.33%)
USD |
NASDAQ |
Jun 14, 16:00
5.18
-0.02
(-0.38%)
After-Hours: 20:00
Lifecore Biomedical Gross Profit (TTM): 27.73M for May 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
May 31, 2023 | 27.75M |
February 28, 2023 | 26.77M |
November 30, 2022 | 33.66M |
August 31, 2022 | 41.27M |
May 31, 2022 | 45.45M |
February 28, 2022 | 41.06M |
November 30, 2021 | 42.64M |
August 31, 2021 | 48.56M |
May 31, 2021 | 54.47M |
February 28, 2021 | 39.92M |
November 30, 2020 | 45.52M |
August 31, 2020 | 40.40M |
May 31, 2020 | 39.39M |
February 29, 2020 | 77.11M |
November 30, 2019 | 78.63M |
August 31, 2019 | 80.00M |
May 31, 2019 | 81.00M |
February 28, 2019 | 79.60M |
November 30, 2018 | 77.84M |
August 31, 2018 | 75.87M |
May 31, 2018 | 78.34M |
February 28, 2018 | 69.21M |
November 30, 2017 | 72.84M |
August 31, 2017 | 76.87M |
May 31, 2017 | 79.21M |
Date | Value |
---|---|
February 28, 2017 | 82.14M |
November 30, 2016 | 71.64M |
August 31, 2016 | 69.95M |
May 31, 2016 | 66.78M |
February 29, 2016 | 66.84M |
November 30, 2015 | 70.80M |
August 31, 2015 | 69.20M |
May 31, 2015 | 65.41M |
February 28, 2015 | 62.88M |
November 30, 2014 | 66.15M |
August 31, 2014 | 64.22M |
May 31, 2014 | 62.56M |
February 28, 2014 | 59.45M |
November 30, 2013 | 56.80M |
August 31, 2013 | 61.53M |
May 31, 2013 | 62.76M |
February 28, 2013 | 64.44M |
November 30, 2012 | 60.10M |
August 31, 2012 | 54.65M |
May 31, 2012 | 52.14M |
February 29, 2012 | 47.98M |
November 30, 2011 | 47.28M |
August 31, 2011 | 46.13M |
May 31, 2011 | 46.70M |
February 28, 2011 | 45.50M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
26.77M
Minimum
Feb 2023
80.00M
Maximum
Aug 2019
47.66M
Average
41.95M
Median
Gross Profit (TTM) Benchmarks
Aquestive Therapeutics Inc | 31.02M |
SELLAS Life Sciences Group Inc | -- |
ADMA Biologics Inc | 111.54M |
Relmada Therapeutics Inc | -- |
Jaguar Health Inc | 8.018M |